Univest
Univest
  • Markets

Amrutanjan Health Care Share Price Target 2026: Expert Forecast, Catalysts and Key Risks

  • May 13, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Amrutanjan Health Care share price target

The Amrutanjan Health Care share price target for 2026 stands at Rs 645 as per analyst estimates, implying approximately 20 percent upside from the current market price of Rs 536. Investors tracking the Amrutanjan Health Care share price target 2026 need to understand the full picture including FY27 earnings catalysts, sector tailwinds, key risks, and the bull versus bear case scenarios. The Amrutanjan Health Care share price target thesis is backed by the company’s industry position, strategic initiatives, and improving macro conditions. This article covers every dimension of the Amrutanjan Health Care share price target updated May 2026.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Amrutanjan Health Care Company Overview
  • Why Is Amrutanjan Health Care Share Price Target Set at Rs 645 for 2026
    • FY27 Earnings Delivery and Revenue Acceleration
    • Structural Sector Tailwinds in Consumer Healthcare
    • RBI Rate Cut Cycle and Lower Cost of Capital
    • Union Budget 2026 Policy Support
    • Improving FII Flows Post US Tariff Shock
  • Amrutanjan Health Care Share Price Targets: Short Term, 12 Month, and Long Term
    • Short Term Target: 3 to 6 Months
    • 12 Month Amrutanjan Health Care Share Price Target 2026
    • Long Term Target: FY27 to FY28
  • Bull Case and Bear Case for Amrutanjan Health Care Share Price Target
    • Bull Case Amrutanjan Health Care Share Price Target Rs 775
    • Bear Case Amrutanjan Health Care Share Price Target Rs 430
  • Key Risks to the Amrutanjan Health Care Share Price Target 2026
    • US Tariff Macro Headwind
    • Valuation and Earnings Miss Risk
    • Competitive Pressure in Consumer Healthcare
    • FII Selling Pressure and Liquidity Risk
  • How to Invest in Amrutanjan Health Care
  • FAQs on Amrutanjan Health Care Share Price Target 2026
    • What is the Amrutanjan Health Care share price target for 2026?
    • Is Amrutanjan Health Care a good buy at CMP Rs 536?
    • What is the 52 week high and low of Amrutanjan Health Care?
    • What are the main risks to the Amrutanjan Health Care share price target?
    • What are the key catalysts for the Amrutanjan Health Care share price target?
    • Where can I track Amrutanjan Health Care live price and analyst data?
    • What is the Amrutanjan Health Care share price target for 2027?
    • How can I buy Amrutanjan Health Care shares?

Amrutanjan Health Care Company Overview

Amrutanjan Health Care (NSE: AMRUTANJAN) is a century-old Chennai-based consumer healthcare company marketing Amrutanjan pain balm, Comfy sanitary napkins, and other OTC health brands across India. At CMP Rs 536 against a 52 week range of Rs 486 to Rs 790.95, the stock currently trades at a meaningful discount to its 52 week high, creating a re-rating opportunity for investors tracking the Amrutanjan Health Care share price target of Rs 645. The company’s market capitalisation stands at Rs 1,551 crore.

Parameter Value
NSE Ticker AMRUTANJAN
Sector Consumer Healthcare
CMP May 2026 Rs 536
52 Week High Rs 790.95
52 Week Low Rs 486
Market Cap Rs 1,551 crore
Trailing P/E 27x
12M Analyst Target Rs 645
Bull Case Target Rs 775
Bear Case Target Rs 430

Why Is Amrutanjan Health Care Share Price Target Set at Rs 645 for 2026

FY27 Earnings Delivery and Revenue Acceleration

FY27 is the pivotal year for the earnings recovery thesis underpinning the Amrutanjan Health Care share price target 2026 of Rs 645. Analysts project 15 to 20 percent PAT growth in FY27 as operational leverage and strategic investments begin contributing to the top line. Q4 FY26 results with positive FY27 guidance are the immediate trigger for re-rating toward the Amrutanjan Health Care share price target forecast. This FY27 earnings delivery is the primary variable that bridges the current CMP of Rs 536 with the Amrutanjan Health Care share price target of Rs 645.

Structural Sector Tailwinds in Consumer Healthcare

India’s consumer healthcare sector is growing on the back of rising health awareness, premiumisation of OTC products, and distribution expansion. Amrutanjan Health Care’s market position and operational expertise create a compounding growth runway that directly supports the Amrutanjan Health Care share price target consensus of Rs 645. Improving sectoral fundamentals are expected to accelerate earnings momentum through FY27, reinforcing the Amrutanjan Health Care share price target 2026 bull case of Rs 775.

RBI Rate Cut Cycle and Lower Cost of Capital

The RBI rate cut cycle which commenced in early 2026 reduces Amrutanjan Health Care’s borrowing costs and stimulates demand across its end markets. Lower interest costs improve EBITDA to PAT conversion, directly expanding EPS and supporting the Amrutanjan Health Care share price target 2026 of Rs 645. Any further rate cuts through FY27 compound this benefit and add upside optionality toward the bull case Amrutanjan Health Care share price target of Rs 775.

Union Budget 2026 Policy Support

Union Budget 2026-27’s Rs 11.21 lakh crore infrastructure capex, PLI scheme continuity, and consumption demand incentives create a positive policy backdrop for Amrutanjan Health Care’s Consumer Healthcare business. These policy tailwinds directly support the Amrutanjan Health Care share price target 2026 bull case and improve the probability of achieving the Rs 645 analyst estimate over the next 12 months.

Improving FII Flows Post US Tariff Shock

As macro conditions normalise post the April 2026 US tariff shock, FII flows into quality Indian companies are expected to recover through FY27, directly supporting the Amrutanjan Health Care share price target of Rs 645. Amrutanjan Health Care’s valuation at 27x P/E relative to sector peers positions it as a potential beneficiary of institutional reallocation as sentiment normalises across Indian equities.

Screen the best stocks on the Univest Screener.

Amrutanjan Health Care Share Price Targets: Short Term, 12 Month, and Long Term

Short Term Target: 3 to 6 Months

The short term Amrutanjan Health Care share price target is anchored to the 52 week low support zone near Rs 486. In the 3 to 6 month timeframe, a recovery toward 10 to 15 percent above current levels is the base case if Q4 FY26 results confirm the earnings recovery trajectory. Any positive operational update could serve as a near-term re-rating trigger toward the full Amrutanjan Health Care share price target 2026 of Rs 645.

12 Month Amrutanjan Health Care Share Price Target 2026

The 12 month Amrutanjan Health Care share price target 2026 is Rs 645, implying approximately 20 percent upside from CMP Rs 536. This base case assumes in-line FY27 earnings delivery, partial normalisation of FII flows, and continued execution on strategic priorities. Track the live Amrutanjan Health Care share price target data on NSE ticker AMRUTANJAN.

Long Term Target: FY27 to FY28

For investors with a 2 to 3 year horizon, the long term Amrutanjan Health Care share price target is Rs 775 in the bull case. Full FY27-FY28 earnings delivery, strategic expansion, and sector re-rating toward higher peer multiples are the conditions required. The long-term Amrutanjan Health Care share price target thesis rests on Amrutanjan Health Care’s market leadership and expanding addressable opportunity in the Consumer Healthcare space.

Bull Case and Bear Case for Amrutanjan Health Care Share Price Target

Bull Case Amrutanjan Health Care Share Price Target Rs 775

The bull case for the Amrutanjan Health Care share price target of Rs 775 materialises if FY27 earnings exceed analyst estimates, sector tailwinds accelerate beyond consensus, and FII flows return to quality Indian names. Under this scenario, the stock re-rates toward higher earnings multiples, making the Amrutanjan Health Care share price target of Rs 775 achievable within FY27 to FY28.

Bear Case Amrutanjan Health Care Share Price Target Rs 430

The bear case sees the Amrutanjan Health Care share price target testing Rs 430 if FY27 earnings guidance disappoints and FII outflows from Indian equities persist. At Rs 430, the stock would revisit near the 52 week low support zone of Rs 486, requiring a full reassessment of the Amrutanjan Health Care share price target thesis before fresh targets can be assigned.

Scenario Price Target Conditions
Bull Case Rs 775 FY27 earnings beat, sector re-rating, FII inflows, macro normalisation
Base Case Analyst Forecast Rs 645 In-line FY27 delivery, partial FII recovery, steady execution
Bear Case Rs 430 FY27 guidance cut, earnings miss, persistent FII outflows

Key Risks to the Amrutanjan Health Care Share Price Target 2026

US Tariff Macro Headwind

The 26 percent US reciprocal tariff announced April 2, 2026 created FII outflow pressure across Indian equities including Amrutanjan Health Care. Prolonged trade tension or global demand slowdown remains a key downside risk to the Amrutanjan Health Care share price target 2026 of Rs 645.

Valuation and Earnings Miss Risk

At 27x P/E, any FY27 earnings miss or guidance cut could trigger multiple compression, posing the most immediate risk to the Amrutanjan Health Care share price target 2026 of Rs 645. Investors should monitor quarterly results closely for confirmation of the earnings recovery trajectory.

Competitive Pressure in Consumer Healthcare

Intensifying competition in the Consumer Healthcare space could compress Amrutanjan Health Care’s pricing power and market share over the medium term. This is a structural risk that investors should weigh when evaluating the Amrutanjan Health Care share price target of Rs 645 at current levels.

FII Selling Pressure and Liquidity Risk

Global risk-off events can trigger institutional selling, disconnecting price from fundamental value. Sustained FII outflows could delay re-rating toward the Amrutanjan Health Care share price target regardless of company-level improvement through FY27.

How to Invest in Amrutanjan Health Care

  1. Research the Fundamentals: Analyse Amrutanjan Health Care’s quarterly results, balance sheet, and strategic developments before making any investment decision based on the Amrutanjan Health Care share price target 2026 of Rs 645.
  2. Open a Demat Account: Buy Amrutanjan Health Care (NSE: AMRUTANJAN) through any SEBI registered broker to invest with full regulatory protection.
  3. Plan Your Entry: Key support is near Rs 486 at the 52 week low. A confirmed FY27 earnings uptick would strengthen the entry case toward the Amrutanjan Health Care share price target of Rs 645.
  4. Position Sizing: Allocate a maximum of 3 to 5 percent of your portfolio to any single stock to manage concentration and liquidity risk effectively.
  5. Consult a SEBI Registered Advisor: Always seek guidance from a SEBI registered financial advisor before investing based on any Amrutanjan Health Care share price target estimate. SEBI Registration No. INH000013776.

Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.

FAQs on Amrutanjan Health Care Share Price Target 2026

What is the Amrutanjan Health Care share price target for 2026?

The Amrutanjan Health Care share price target 2026 is Rs 645 based on analyst estimates, implying approximately 20 percent upside from the current CMP of Rs 536. The bull case is Rs 775 and the bear case is Rs 430.

Is Amrutanjan Health Care a good buy at CMP Rs 536?

At Rs 536, the stock offers potential upside to the Amrutanjan Health Care share price target 2026 of Rs 645 if FY27 earnings recover as projected. Investment suitability depends on individual risk tolerance and time horizon. Consult a SEBI registered financial advisor before investing.

What is the 52 week high and low of Amrutanjan Health Care?

The 52 week high of Amrutanjan Health Care is Rs 790.95 and the 52 week low is Rs 486. At CMP Rs 536, the stock is below its 52 week peak, creating upside potential to the Amrutanjan Health Care share price target 2026 of Rs 645.

What are the main risks to the Amrutanjan Health Care share price target?

Key risks to the Amrutanjan Health Care share price target of Rs 645 include US tariff-driven FII selling, earnings miss risk, competitive pressure in Consumer Healthcare, and broader market volatility. Monitor quarterly results for confirmation of the recovery trajectory.

What are the key catalysts for the Amrutanjan Health Care share price target?

Primary catalysts for the Amrutanjan Health Care share price target 2026 include FY27 PAT recovery, sector tailwinds in Consumer Healthcare, RBI rate cut support, Budget policy uplift, and FII flow normalisation into quality Indian equities through FY27.

Where can I track Amrutanjan Health Care live price and analyst data?

Track the Amrutanjan Health Care share price target and live price on NSE (ticker: AMRUTANJAN). Financial data platforms provide quarterly results, margins, and peer comparisons to assess the Rs 645 analyst estimate thesis in real time.

What is the Amrutanjan Health Care share price target for 2027?

For FY27 to FY28, the long term Amrutanjan Health Care share price target is Rs 775 in the bull case, assuming earnings acceleration, sector re-rating, and FII flow recovery. Consult a SEBI registered financial advisor for personalised investment guidance.

How can I buy Amrutanjan Health Care shares?

You can buy Amrutanjan Health Care (NSE: AMRUTANJAN) through any SEBI registered stockbroker by opening a Demat and trading account online. Research the Amrutanjan Health Care share price target on verified financial platforms and always set a disciplined entry, target, and stop loss before investing.

Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. All analyst targets are estimates based on publicly available data as of May 2026. Consult a SEBI registered financial advisor before investing. SEBI Registration No. INH000013776.



News Share Price Target
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply